切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Rho-kinase - Adenosine A2A Receptors - PTK - CETP

10 件产品

每页
清除全部
  1. Regadenoson
    B5904 Regadenoson
     1 Citation
    中文名: 类伽腺苷
    Target: Adenosine A2A Receptors
    Summary: A2A腺苷受体激动剂
      ≥18.05 mg/mL
      insoluble in H2O
  2. SCH 58261
    B6995 SCH 58261
    Target: Adenosine A2A Receptors
    Summary: A2A腺苷受体竞争性拮抗剂
      ≥34.5 mg/mL
      insoluble in H2O
  3. Istradefylline (KW-6002)
    A8454 Istradefylline (KW-6002)
    中文名: 伊曲茶碱
    Target: Adenosine A2A Receptors
    Summary: 选择性A2A受体拮抗剂
      ≥8.78 mg/mL
      insoluble in H2O
  4. Butein
    A2689 Butein
    中文名: 紫铆因,紫铆查尔酮
    Target: Src|STAT|EGFR|Angiotensin-Converting Enzymes (ACEs)|5-Lipoxygenases|PTK|enoyl-acyl-carrier protein reductase
    Summary: 蛋白激酶抑制剂
      ≥13.6 mg/mL
      insoluble in H2O
  5. Genistein
    A2198 Genistein
    中文名: 金雀异黄酮,染料木素
    Target: Estrogen and Related Receptors|PPAR|PTK
    Summary: ER agonist
      ≥13.5 mg/mL
      insoluble in H2O
  6. Tozadenant
    A3885 Tozadenant
    Target: Adenosine A2A Receptors
    Summary: 腺苷2A受体拮抗剂
      ≥20.35 mg/mL
      insoluble in H2O
  7. Preladenant
    A3735 Preladenant
    Target: Adenosine A2A Receptors
    Summary: 腺苷A2A受体拮抗剂
      ≥7.3 mg/mL
      insoluble in H2O
  8. Hydroxyfasudil
    A3478 Hydroxyfasudil
    中文名: 羟基法舒地尔
    Target: ROCK|Rho-kinase
    Summary: Rho激酶抑制剂和血管扩张剂
      Soluble in DMSO
  9. Evacetrapib (LY2484595)
    A4377 Evacetrapib (LY2484595)
    Target: CETP
    Summary: 强效的CETP选择性抑制剂
      ≥32.1 mg/mL
      insoluble in H2O
  10. Anacetrapib (MK-0859)
    A4375 Anacetrapib (MK-0859)
     1 Citation
    中文名: 安塞曲匹
    Target: CETP
    Summary: RhCETP/突变型 CETP(C13S) 抑制剂
      ≥31.9 mg/mL
      insoluble in H2O

10 件产品

每页